RS50137B - Nova so 5-/4-/2-(n-metil-n-(2-piridil) amino)etoksi/benzil/ tiazolidin-2,4-dion hidrohlorid monohidrat - Google Patents

Nova so 5-/4-/2-(n-metil-n-(2-piridil) amino)etoksi/benzil/ tiazolidin-2,4-dion hidrohlorid monohidrat

Info

Publication number
RS50137B
RS50137B YUP-816/01A YUP81601A RS50137B RS 50137 B RS50137 B RS 50137B YU P81601 A YUP81601 A YU P81601A RS 50137 B RS50137 B RS 50137B
Authority
RS
Serbia
Prior art keywords
thiazolidine
pyridyl
benzyl
amino
salt5
Prior art date
Application number
YUP-816/01A
Other languages
English (en)
Inventor
Paul David James Blackler
Robert Gordon Giles
Andrew Simon Craig
Michael John Sasse
Original Assignee
Smithkline Beecham P.L.C.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C., filed Critical Smithkline Beecham P.L.C.,
Publication of YU81601A publication Critical patent/YU81601A/sh
Publication of RS50137B publication Critical patent/RS50137B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

5-[4-[2-(N-metil-N-(2-piridil)amino)etoksi]benzil] tiazolidin-,4-dion, hidrohloridmonohidrat, naznacen time, što: (i) daje infracrveni spektar sa pikovima na 3358, 2764, 1245, 833 i 760cm-1; i/ili (ii) daje rendgeski dijagram praha (XRPD) sa pikovima na 15.0, 17.7, 23.0, 30.0 i 31.4°20. Prijava sadrži još 10 patentnih zahteva.
YUP-816/01A 1999-04-20 2000-04-19 Nova so 5-/4-/2-(n-metil-n-(2-piridil) amino)etoksi/benzil/ tiazolidin-2,4-dion hidrohlorid monohidrat RS50137B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9909075.5A GB9909075D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical

Publications (2)

Publication Number Publication Date
YU81601A YU81601A (sh) 2004-09-03
RS50137B true RS50137B (sr) 2009-03-25

Family

ID=10851922

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-816/01A RS50137B (sr) 1999-04-20 2000-04-19 Nova so 5-/4-/2-(n-metil-n-(2-piridil) amino)etoksi/benzil/ tiazolidin-2,4-dion hidrohlorid monohidrat

Country Status (42)

Country Link
EP (2) EP1173437B1 (sr)
JP (2) JP4283450B2 (sr)
KR (1) KR100677815B1 (sr)
CN (2) CN101125851A (sr)
AP (1) AP1680A (sr)
AR (2) AR023567A1 (sr)
AT (1) ATE262524T1 (sr)
AU (1) AU773112B2 (sr)
BG (1) BG65428B1 (sr)
BR (1) BR0009898A (sr)
CA (1) CA2370270A1 (sr)
CO (1) CO5170420A1 (sr)
CZ (1) CZ300934B6 (sr)
DE (1) DE60009276T2 (sr)
DK (1) DK1173437T3 (sr)
DZ (1) DZ3163A1 (sr)
EA (1) EA004769B1 (sr)
EG (1) EG23946A (sr)
ES (1) ES2214267T3 (sr)
GB (1) GB9909075D0 (sr)
HK (1) HK1045304B (sr)
HR (1) HRP20010771B1 (sr)
HU (1) HUP0200785A3 (sr)
IL (1) IL146077A0 (sr)
MA (1) MA26784A1 (sr)
MX (1) MXPA01010695A (sr)
MY (1) MY125209A (sr)
NO (1) NO320573B1 (sr)
NZ (1) NZ515164A (sr)
OA (1) OA11867A (sr)
PE (1) PE20010047A1 (sr)
PL (1) PL351115A1 (sr)
PT (1) PT1173437E (sr)
RS (1) RS50137B (sr)
SI (1) SI1173437T1 (sr)
SK (1) SK284990B6 (sr)
TR (1) TR200103041T2 (sr)
TW (1) TWI291463B (sr)
UA (1) UA72245C2 (sr)
UY (1) UY26113A1 (sr)
WO (1) WO2000063206A2 (sr)
ZA (1) ZA200108721B (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
JP2005513038A (ja) * 2001-11-21 2005-05-12 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー ５−［４−［２−（ｎ−メチル−ｎ−（２−ピリジル）アミノ）エトキシ］ベンジル］チアゾリジン−２，４−ジオンベンゼンスルホン酸塩；その製造方法；多形体ｉ、ｉｉおよびｉｉｉ；および医薬上活性な成分としてのその使用
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
AU773112B2 (en) 2004-05-20
HUP0200785A2 (en) 2002-08-28
JP4283450B2 (ja) 2009-06-24
EA004769B1 (ru) 2004-08-26
AR023567A1 (es) 2002-09-04
DE60009276D1 (de) 2004-04-29
HUP0200785A3 (en) 2004-03-29
KR100677815B1 (ko) 2007-02-05
HK1045304B (zh) 2004-12-24
HK1045304A1 (en) 2002-11-22
UY26113A1 (es) 2000-12-29
IL146077A0 (en) 2002-07-25
PT1173437E (pt) 2004-06-30
JP2009161544A (ja) 2009-07-23
WO2000063206A3 (en) 2001-02-22
BG106120A (en) 2002-05-31
TR200103041T2 (tr) 2002-03-21
NO320573B1 (no) 2005-12-27
YU81601A (sh) 2004-09-03
GB9909075D0 (en) 1999-06-16
EP1173437B1 (en) 2004-03-24
EP1411054A1 (en) 2004-04-21
ATE262524T1 (de) 2004-04-15
OA11867A (en) 2006-03-02
SI1173437T1 (en) 2004-06-30
TWI291463B (en) 2007-12-21
NO20015105L (no) 2001-12-19
DE60009276T2 (de) 2004-08-26
DK1173437T3 (da) 2004-07-12
DZ3163A1 (fr) 2000-10-26
CZ20013758A3 (cs) 2003-05-14
EA200101102A1 (ru) 2002-04-25
CA2370270A1 (en) 2000-10-26
MY125209A (en) 2006-07-31
ES2214267T3 (es) 2004-09-16
JP2002542243A (ja) 2002-12-10
PE20010047A1 (es) 2001-03-10
CN1327446A (zh) 2001-12-19
CO5170420A1 (es) 2002-06-27
HRP20010771B1 (en) 2005-06-30
NZ515164A (en) 2004-02-27
CZ300934B6 (cs) 2009-09-16
NO20015105D0 (no) 2001-10-19
SK284990B6 (sk) 2006-04-06
HRP20010771A2 (en) 2002-12-31
AP2001002332A0 (en) 2001-12-31
SK14892001A3 (sk) 2002-02-05
CN101125851A (zh) 2008-02-20
ZA200108721B (en) 2002-09-13
BG65428B1 (bg) 2008-07-31
UA72245C2 (uk) 2005-02-15
MXPA01010695A (es) 2002-06-04
BR0009898A (pt) 2002-04-16
PL351115A1 (en) 2003-03-24
MA26784A1 (fr) 2004-12-20
EG23946A (en) 2008-01-22
EP1173437A2 (en) 2002-01-23
AR023563A1 (es) 2002-09-04
WO2000063206A2 (en) 2000-10-26
AU4131100A (en) 2000-11-02
AP1680A (en) 2006-11-27
KR20010112446A (ko) 2001-12-20

Similar Documents

Publication Publication Date Title
RS51343B (sr) Nova kompozicija i njena upotreba
IL106777A (en) Monohydrate of 5-(2-(4-(1, 2-benzisothiazol-3-yl)-1- piperazinyl)-ethyl)-6- chloro-1, 3-dihydro-2h- indole-2-one hydrochloride and pharmaceutical compositions comprising it
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
RS50136B (sr) Derivati tiazolidindiona i njihova upotreba kao antidijabetika
RS50137B (sr) Nova so 5-/4-/2-(n-metil-n-(2-piridil) amino)etoksi/benzil/ tiazolidin-2,4-dion hidrohlorid monohidrat
CY1105252T1 (el) Το υδροχλωρικο αλας της 5-[4-[2-(ν-μεθυλο-ν-(2-πυριδυλο)αμινο)-αιθοξυ]βενζυλο]θειαζολιδινο-2,4-διονης
AP9901696A0 (en) Composition comprising 5-(4-(2-(N-methyl-N-2-pyridyl)amino) ehtoxy benzyl)thiazolidine-2,4-dione
DE60115062D1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
NO20012673D0 (no) Nytt farmasöytisk preparat og fremgangsmåte for dets fremstilling
PT1446404E (pt) Edisilatos de rosiglitazona e sua utilizacao como antidiabeticos
EA200300004A1 (ru) Гидроиодид 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона в качестве фармацевтического препарата
CY1107767T1 (el) Παραγωγο θειαζολιδινοδιονης και χρηση αυτου σαν αντιδιαβητικο
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
ECSP003435A (es) Nuevos compuestos
ECSP034466A (es) Farmaceutico novedoso
ATE349444T1 (de) 5-(4-(2-(n-methyl-n-(2- pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-di n-benzolsulfonat; prozess zu seiner herstellung; polymorphe i, ii und iii davon; und seine verwendung als pharmazeutischer wirkstoff
EA200700003A1 (ru) Соль фосфорной кислоты и 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона и способ её получения